Hum. Reprod. Advance Access originally published online on May 18, 2006
Human Reproduction 2006 21(9):2340-2345; doi:10.1093/humrep/del158
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Decrease of both stem cell factor and clusterin mRNA levels in testicular biopsies of azoospermic patients with constitutive or idiopathic but not acquired spermatogenic failure
INSERM, U 418, Hôpital Debrousse, INRA, U 1245 and Université Claude Bernard Lyon 1, Lyon, France
1 To whom correspondence should be addressed at: Département de Médecine de la Reproduction, Pavillon K1, Hôpital Edouard Herriot, Place d’Arsonval, 69437 Lyon Cedex 03, France. E-mail: herve.lejeune{at}chu-lyon.fr
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and methodsResultsDiscussionConclusionAcknowledgementsReferences |
|---|
BACKGROUND: Sertoli cells nurse germ cells during spermatogenesis, and alterations of Sertoli cell functions have been suggested in cases of spermatogenic failures. METHODS: In this work, we measured stem cell factor (SCF) and clusterin mRNA levels, by quantitative RT–PCR, in RNA extracted from testicular biopsies of 49 azoospermic patients classified according to testicular histology as having normal spermatogenesis or spermatogenic failure. RESULTS: When related to the percentage of Sertoli cells counted on a histological section of a neighbouring tissue sample, SCF and clusterin mRNA levels were significantly lower in the ‘spermatogenic failure’ group compared with the control group (P = 0.0297 and P = 0.0043, respectively). These levels were also significantly lower in the cases of ‘constitutive’ (cryptorchidism and Yq microdeletion) and ‘idiopathic’ spermatogenic failures when compared with the control group; conversely, they were not significantly decreased in the group with ‘acquired spermatogenic failure’ (orchitis, testicular traumatism, chemoradiotherapy and varicocele). CONCLUSIONS: These data further demonstrate an alteration of Sertoli cell functions in some human spermatogenic failures and suggest that a lack of Sertoli cell maturation may be involved in cases of constitutive or idiopathic spermatogenic failures.
Key words: azoospermia/clusterin/Sertoli/spermatogenesis/stem cell factor
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and methodsResultsDiscussionConclusionAcknowledgementsReferences |
|---|
Sertoli cells nurse germ cells during spermatogenesis. The crosstalk between the Sertoli and the germ cells involves many paracrine/autocrine factors and has been studied mainly in animal models and rarely in the human species (Mruk and Cheng, 2004
). Alterations of Sertoli cell morphology (Nistal et al., 1998) and protein production as revealed by immunocytochemistry (Sharpe et al., 2003) have been suggested in cases of spermatogenic failures. These alterations are important to consider when pursuing the aim of developing therapeutic procedures involving testicular paracrine factors. Indeed, if the production of a Sertoli cell-derived factor is altered in some case of spermatogenetic failure, its normalization, by a therapeutic intervention in vivo or in vitro, should improve spermatogenesis. Such factors have already been studied in human testicular biopsies by immunocytochemistry and in situ hybridization (Bar-Shira Maymon et al., 2000, 2002; Defamie et al., 2003; Sharpe et al., 2003). However, whereas these morphological methods allow cell localization of the factors or of their mRNA, they do not allow an accurate quantification of their production. The small amount of tissue available in clinical practice has precluded the use of peptide measurement. Hence, quantitative RT–PCR would be the method of choice to estimate the production of paracrine factors by the Sertoli cells. Furthermore, measuring Sertoli cell production of paracrine factors in pathological samples is difficult because of the cellular heterogeneity of the testicular tissue samples and the large variations in the cellular composition of the testis according to the degree and type of spermatogenic failure. Stem cell factor (SCF) is one of the paracrine factors produced by the Sertoli cells (Rossi et al., 1991). Mutations in the W (dominant White spotting) and Sl (Steel) loci in the mouse, encoding the c-kit receptor and the c-kit ligand (SCF), respectively, cause sterility as they are required for the migration and proliferation of primordial germ cells (Sette et al., 2000). Moreover, SCF stimulates spermatogonial proliferation (Rossi et al., 1993) and appears involved in regulating latter stages of spermatogenesis (Vincent et al., 1998; Yan et al., 2000) together with reducing germ cell apoptosis (Yan et al., 2000).
Clusterin, also referred to as sulphated glycoprotein 2 (Tenniswood et al., 1998), has been shown to be produced within the testis by the Sertoli cells (Morales et al., 1987). Although its role is far from being understood, an anti-apoptotic effect of clusterin on germ cells has been reported (O’Bryan et al., 1994; Bailey et al., 2002). However, clusterin knockout (KO) mice have only subtle alterations of spermiation and spermatid resistance to heat stress (Bailey et al., 2002). Clusterin mRNA levels have been shown to increase with Sertoli cell maturation between day 10 and day 20 of age in the rat and to remain very stable thereafter (Morales et al., 1987; Plotton et al., 2005). Clusterin might therefore be considered as a marker of Sertoli cell maturation.
In this work, we measured both SCF and clusterin mRNA levels by quantitative RT–PCR in RNA extracted from testicular biopsies of 49 azoospermic patients classified according to their testicular histology and the aetiology of their spermatogenic failure.
|
Materials and methods |
|---|
|
TopAbstractIntroductionMaterials and methodsResultsDiscussionConclusionAcknowledgementsReferences |
|---|
Patients
A total of 49 patients (36.8 ± 7 years; mean ± SD) had a testicular biopsy for sperm extraction at the Départment de Médecine de la Reproduction because of azoospermia. Azoospermic patients with an abnormal karyotype were not included in this study.
Medical history and clinical findings were recorded for each patient. Testicular volumes were measured using Prader’s orchidometer.
Sperm analysis was performed according to the World Health Organization’s recommendations (1999) including a centrifugation step of the semen. Azoospermia was confirmed by a second analysis. Plasma FSH levels were assayed by radioimmunoassay (normal range 1.2–7.6 IU/l); plasma Inhibin B levels were assayed by enzyme-linked immunosorbent assay (ELISA) (DSL-10684100, normal range 55–309 ng/l).
Seminal tract obstruction was assessed by seminal biochemistry (
-glucosidase, fructose and citric acid) and echography. The presence of a Yq microdeletion was investigated by standard procedures.
Testicular biopsies
Open testicular biopsies were carried out under general anaesthesia. One sample of testicular tissue was immediately immersed in RNA later AMBION® (Austin, TX, USA), (catalogue no. 7020) for RNA extraction. A neighbouring sample was fixed in Bouin’s solution for histological study. Spermatozoa were extracted by mechanical dilaceration for ICSI.
Ethics
The procedure has been authorized, according to the French legislation, by the ‘Comité Consultatif de Protection des Personnes soumises à la Recherche Biomédicale’. Informed consent was obtained from all participants.
Testicle histology
Fixed testicular tissue samples were paraffin-embedded, cut at 3 µm and stained by haematoxylin eosin standard procedure.
Histological classification
The seminiferous tubules were classified according to the Johnsen’s score (Johnsen, 1970). This allowed us to assign the patients to the following groups:
- Normal spermatogenesis: a majority (>50%) of the spermatogenic tubes had a Johnsen’s score of 10 (normal) or 9 (disorganized architecture, but with
to 10 sperm cells). This group was considered as the control group of this study.
- Spermatogenic failure: when less than 50% of the spermatogenic tubes exhibited a Johnsen’s score of 10 or 9. To investigate the role of the severity of the spermatogenic failure, this latter group was further divided into the following histological subgroups:
- Moderate hypospermatogenesis: less than 50% of the seminiferous tubes had a Johnsen’s score of 9 or 10 but >10% of the seminiferous tubes had a Johnsen’s score of 8 (<10 sperm cells).
- Severe hypospermatogenesis with few sperm cells: no seminiferous tubes had a Johnsen’s score of 9 or 10 and
to 10% of the seminiferous tubes had a Johnsen’s score of 8 (<10 sperm cells).
- Severe hypospermatogenesis without sperm cells: no mature sperm cell was seen but at least one seminiferous tube had a Johnsen’s score between 7 and 3 (presence of immature germ cells).
- Sertoli cell-only syndrome: the seminiferous tubes had a Johnsen’s score to 2 (no germ cells).
- Moderate hypospermatogenesis: less than 50% of the seminiferous tubes had a Johnsen’s score of 9 or 10 but >10% of the seminiferous tubes had a Johnsen’s score of 8 (<10 sperm cells).
Aetiological classification
The aetiology of the spermatogenic failure was defined from the clinical records. Accordingly, the patients were assigned to the following aetiological subgroups:
- Acquired spermatogenic failure: in case of history of orchitis, testicular trauma, chemoradiotherapy or presence of a voluminous varicocele (detected at scrotal visual inspection);
- Constitutive spermatogenic failure: in case of history of cryptorchidism or in case of AZFc microdeletion;
- Idiopathic spermatogenic failure: when no aetiological factor could be identified.
Proportion of Sertoli cells in biopsies
Because the number and/or volume of Sertoli cells, germ cells and interstitial cells may vary according to the spermatogenic alteration, the variations in the proportion of Sertoli cells in the testis samples were roughly estimated by making the ratio of the number of Sertoli cells to the total number of cells counted on randomly chosen histological sections of the biopsies.
Vimentin immunoreactivity was used to identify Sertoli cells in histological sections. An anti-vimentin-specific monoclonal antibody (Dako, France) was used at a dilution of 1 : 1000. Vimentin immunoreactivity was revealed by a biotin-coupled goat anti-mouse antibody incubated with streptavidine-coupled horseradish peroxidase (Dako, Trappes, France) giving a brown colouration to the Sertoli cells after reaction with diaminobenzidine. The cell nuclei were then stained with haematoxylin.
The cells were classified according to the following criteria: Sertoli cells (vimentin-positive cells within the seminiferous tubule), germ cells (vimentin-negative cells within the seminiferous tubule) and interstitial cells (vimentin-positive cells outside the tubules) (Plotton et al., 2005).
For each patient, at least 1000 cells were counted in randomly chosen microscopic fields at 1000x magnification. The results (Table IV) were similar in our control group and in the subjects younger than 40 years in the study of Johnson et al. 1984.
RNA extraction
RNA extraction was performed with the AMBION® kit according to the manufacturer’s instructions. The quality of the total RNA preparation was checked by 1% agarose gel electrophoresis in the presence of ethidium bromide showing the typical 18S and 28S bands.
Competitive RT–PCR
As previously described in detail (Plotton et al., 2005), this method is based on the use of a synthetic RNA competitor which allows the monitoring of both the reverse transcription and the polymerase chain reactions (PCRs). The stability of this RNA is increased by incorporating modified nucleotides, making the competitor RNA resistant to ribonucleases.
Competitor synthesis and quantification
The construction and quantification of the competitor RNAs with modified nucleotides was performed with the AMBION® RT–PCR competitor construction kit (catalogue no. 1356), according to the manufacturer’s instructions.
The sequences used for primer synthesis (Table I), spanning different exons, were chosen according to the published human clusterin, accession no. M64722
[GenBank]
(Wong et al., 1993) and human SCF, accession no. M59964
[GenBank]
(Martin et al., 1990).
|
Competitive RT–PCR
Single-strand cDNAs were synthesized by reverse transcription using the same primer (P4) from the mRNA to be quantified and from the competitor RNA added in a known amount in the same tube. The reverse transcription was performed for 1 h at 37°C, in a volume of 20 µl/tube: 200 units MLVT reverse transcriptase (Invitrogen, Cergy Pontoise, France), 10 mM DTT, 1.25 mM of each dNTP, 0.3 µl RNAsine, 15 pmole P4 primer, 0.01 µg total RNA and the following amount of RNA competitor: 5 x 105, 1 x 106, 2 x 106, 5 x 106, 1 x 107 and 2 x 107 copies for clusterin or 0.1 µg total RNA and the following amount of RNA competitor: 2 x 104, 5 x 104, 1 x 105, 2 x 105, 5 x 105 and 1 x 106 copies for SCF.
Two microlitres of reverse transcription products were subjected to PCR in a volume of 100 µl/tube containing 50 pmoles of P1 primer, 50 pmoles of P3 primer and 0.25 mM of each dNTP. After a denaturation step (5 min at 94°C), 2 units/tube of Taq polymerase (Roche Diagnostics, Meylan, France) were added while the temperature was maintained at 80°C; then the PCR was performed for 40 cycles: 94°C for 1 min, 55°C for 2 min and 72°C for 1 min. The RT–PCR products obtained from the mRNA and from the synthetic RNA competitors were, respectively, 348 and 273 bp for clusterin and 429 and 322 bp for hSCF. They were resolved with 1.5% agarose gel electrophoresis in the presence of ethidium bromide. Photographs of ethidium bromide UV fluorescence of the RT–PCR product bands were subjected to densitometry scanning and analysed with the NIH-IMAGE software. The ratio of the RT–PCR products from the mRNA to the RT–PCR products from the competitor RNA was calculated and plotted against the initial competitor RNA concentration on a bi-logarithmic scale. The regression line was calculated and the initial concentration of mRNA was determined as the competitor concentration corresponding to ratio equal to 1.
The intra- and inter-assay coefficients of variation were, respectively, 14.4 and 29.3% for clusterin mRNA and 17.7 and 34.7% for SCF mRNA, as determined by repeated measurements both (n = 12) of the same RNA sample.
Statistical analysis
Because the number of observations in each group was insufficient to assess the normality of the distributions, the results of each group were compared with the ‘normal spermatogenic group’ by the non-parametric Mann–Whitney U-test. The relationship between the quantitative parameters and the severity of the spermatogenic failure was studied by the non-parametric Spearman’s Rank correlation test between the parameter values and the values 1, 2, 3, 4 and 5 affecting to the histologic subgroups, ‘normal spermatogenesis’, ‘moderate hypospermatogenesis’, ‘severe hypospermatogenesis with few sperm cells’, ‘severe hypospermatogenesis without sperm cells’ and ‘Sertoli cell-only syndrome’ as defined above. P < 0.05 was considered significant.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and methodsResultsDiscussionConclusionAcknowledgementsReferences |
|---|
The distribution of the 49 azoospermic patients among the control and spermatogenic failure groups and among the histological and aetiological subgroups is given in Table II. The cross-tabulation of the histological and aetiological subgroups is given in Table III; it did not show a link between the severity and the aetiology of the spermatogenic failure.
|
|
In the 13 cases of ‘normal spermatogenesis’ and in the eight cases of ‘moderate hypospermatogenesis’, a reproductive tract obstruction was found. A seminal tract obstruction was also found in three cases of ‘severe spermatogenesis with few sperm cells’ and in one case of ‘Sertoli cell-only syndrome’.
As expected, FSH plasma levels were significantly higher and Inhibin B plasma levels and testis volumes were significantly lower in the ‘spermatogenic failure’ group than in controls (Table II). The percentage of Sertoli cells relative to the total number of testicular cells counted on histological sections was higher (P = 0.0016) in the ‘spermatogenic failure’ group (Table IV); it increased according to the severity of the spermatogenic failure assessed by histological evaluation in subgroups (rho = +0.705; P < 0.0001).
|
When related to the amount of total RNA, the SCF and clusterin mRNA levels were not different between the ‘spermatogenic failure’ and the ‘control’ groups. However, when related to the percentage of Sertoli cells, SCF and clusterin mRNA levels were significantly lower in the ‘spermatogenic failure’ group compared with the ‘control’ group (P = 0.0297 and 0.0043, respectively) (Table IV).
In each histological subgroup, SCF mRNA levels expressed relative to the percentage of Sertoli cells were lower than in the ‘control’ group, but the decreases did not reach statistical significance. By contrast, these levels were significantly lower in the ‘constitutive’ and in the ‘idiopathic’ groups than in the control group but were not decreased in the ‘acquired’ group.
The decreases of clusterin mRNA levels expressed relative to the percentage of Sertoli cells were significant for all the histological subgroups but not for the ‘moderate hypospermatogenesis’ subgroup. As for the aetiological subgroups, the pattern was similar to SCF mRNA levels, with a significant decrease in the ‘constitutive’ and the ‘idiopathic’ groups but not in the ‘acquired’ subgroup (Table IV).
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and methodsResultsDiscussionConclusionAcknowledgementsReferences |
|---|
In this work, we measured the mRNA levels of SCF and clusterin (which are both produced by the Sertoli cells), by quantitative RT–PCR, in testicular biopsies obtained during a programme of testicular sperm extraction (TESE) in azoospermic patients. When the SCF and clusterin mRNA levels were expressed relative to the amount of total RNA, no statistical differences could be demonstrated between the ‘control’ group with normal spermatogenesis and the group with spermatogenic failure. However, the measured levels depend on both the amount of mRNA produced by the Sertoli cells and the proportion of RNA of Sertoli cell origin in the samples. Because hypospermatogenesis and especially Sertoli cell-only syndrome are characterized by a reduction in the number of germ cells, these pathologies should lead to an increase in the proportion of Sertoli cells in the testis tissue samples.
Indeed, when the number of Sertoli cells counted on histological sections of the biopsies was related to the total number of cells counted on the same sections, the ratio increased with the severity of the spermatogenic failure. Conversely, we showed in a previous work that the ratio of Sertoli cells in relation to the total number of cells counted on histological sections decreases during post-natal development of the rat, as the number of germ cells increases in the testis (Plotton et al., 2005).
It must be underlined that the ratio of the number of Sertoli cells to the total number of cells counted on histological sections was in no way aiming to be an estimation of the number of Sertoli cells in the testis; this requires much more sophisticated methodologies to be determined (Wreford, 1995). However, the ratio provides evidence that the proportion of Sertoli cells in testis samples varied according to the pathological conditions, as previously shown for experimentally-induced spermatogenesis alterations (Plotton et al., 2005).
When we took into account the proportion of RNA of Sertoli cell origin in the tissue samples by relating the SCF and clusterin mRNA levels to the ratio of Sertoli cell number to the total number of cells counted on histological sections, we found that both SCF and clusterin mRNA levels were lower in cases of spermatogenic failure than in the control group of patients with obstructive azoospermia and normal spermatogenesis at histology. These quantitative data demonstrate that the gene expression of clusterin and SCF by Sertoli cells was reduced in cases of spermatogenic failure as previously suggested by immunohistochemical studies (O’Bryan et al., 1994; Fujita et al., 2005).
As SCF acts on the germ cells to stimulate spermatogenesis, the decrease of its mRNA levels in cases of spermatogenic failure suggests strongly that the paracrine control of Sertoli cells on germ cells was decreased in many cases of human spermatogenic failure. However, it should be noted that whereas the levels of SCF mRNA measured in our study did not appear to be related to the intensity of the spermatogenesis alteration, a discrimination between ‘acquired’ and ‘constitutive/idiopathic’ pathologies could be made on this parameter because ‘acquired’ pathologies did not result in a decrease in the production of SCF by the Sertoli cells. Hence, it seems reasonable to suggest that in such cases Sertoli cell dysfunction is not the primordial cause of spermatogenesis failure. This hypothesis is strengthened by the fact that, in the ‘acquired’ group, the levels of clusterin mRNA also were not different from those of the ‘control’ group (discussed below).
Experimental alteration of spermatogenesis by methoxy-acetic acid or a long-acting GnRH agonist in the adult rat did not modify clusterin mRNA levels (Plotton et al., 2005). By contrast, we observed a decrease of clusterin mRNA levels in cases of ‘idiopathic/constitutive’ human spermatogenic failure. The only situation in which clusterin mRNA levels are low in the rat is the immature animal (Morales et al., 1987; Plotton et al., 2005). Thus, the decrease of clusterin mRNA levels in cases of ‘idiopathic/constitutive’ human spermatogenic failure may suggest an alteration of the maturation of Sertoli cells. This hypothesis has been already proposed on the morphological aspect of Sertoli cells in testicular biopsies of infertile men (Schulze et al., 1976; Nistal et al., 1990, 1998) as well as on the persistence of a strong immunostaining of those proteins which decrease during normal maturation of the testis: AMH (Tran et al., 1987), M2A antigen (Baumal et al., 1989) and cytokeratin 18 (Bar-Shira Maymon et al., 2000) or the maintenance of a weak immunostaining of proteins which increase during normal testis maturation: androgen receptor (Regadera et al., 2001) and Connexin 43 (Defamie et al., 2003). Hence, our results sustain the hypothesis of a deficit of maturation of Sertoli cells in some cases of human spermatogenic failure leading to a pattern of gene expression similar to that of immature Sertoli cells.
The alteration of the maturation process of Sertoli cells in cases of human spermatogenic failure could be related to the fact that experimental alterations of Sertoli cell maturation in animal models have been shown to induce a reduction of germ cells in adults (Sharpe et al., 2003). Thus, some human spermatogenic failure could be primarily because to a Sertoli cell dysfunction. Making the diagnosis of the cases in which the Sertoli cell immaturity is the cause of the spermatogenic failure would be of clinical interest, opening the possibility of therapeutic action on Sertoli cells by treating the patients, or their germ cells in seminiferous tubule cultures, with factors inducing Sertoli cell maturation or by mimicking the microenvironment provided by mature Sertoli cells. Studies of the markers of Sertoli cell differentiation in experimental animal models and in cases of spermatogenic failure of known origin should therefore be developed.
|
Conclusion |
|---|
|
TopAbstractIntroductionMaterials and methodsResultsDiscussionConclusionAcknowledgementsReferences |
|---|
When related to the proportion of Sertoli cells in the tissue sample, both testicular clusterin and SCF mRNA levels were decreased in cases of human ‘constitutive’ and ‘idiopathic’ spermatogenic failure. This might indicate a defect in the maturation process of the Sertoli cells. Further investigations are needed to determine whether, and in which cases, the alteration of Sertoli cell maturation is the cause of the spermatogenic failure, and whether therapeutic action enhancing Sertoli cell functions might improve spermatogenesis.
|
Acknowledgements |
|---|
|
TopAbstractIntroductionMaterials and methodsResultsDiscussionConclusionAcknowledgementsReferences |
|---|
The authors thank the staff of the Département de Médecine de la Reproduction and more especially for their specific help: M.Benchaib, R.Bouvier, B.Cuzin, J.Lornage, M.Mohammad and B.Salle. This work was supported by grants from INSERM, INRA, Université Claude Bernard Lyon 1 and Hospices Civils de Lyon.
|
References |
|---|
|
TopAbstractIntroductionMaterials and methodsResultsDiscussionConclusionAcknowledgementsReferences |
|---|
Bailey RW, Aronow B, Harmony JA, Griswold MD. (2002) Heat shock-initiated apoptosis is accelerated and removal of damaged cells is delayed in the testis of clusterin/ApoJ knock-out mice. Biol Reprod 66:41042–1053.
Bar-Shira Maymon B, Paz G, Elliott DJ, Hammel I, Kleiman SE, Yogev L, Hauser R, Botchan A, Yavetz H. (2000) Maturation phenotype of Sertoli cells in testicular biopsies of azoospermic men. Hum Reprod 15:71537–1542.
Bar-Shira Maymon B, Yavetz H, Schreiber L, Paz G. (2002) Immunohistochemistry in the evaluation of spermatogenesis and Sertoli cell’s maturation status. Clin Chem Lab Med 40:3217–220.[CrossRef][ISI][Medline]
Baumal R, Bailey D, Giwercman A, Skakkebaek N, Stratis M, Marks A. (1989) A novel maturation marker for human Sertoli cells. Int J Androl 12:5354–359.[ISI][Medline]
Defamie N, Berthaut I, Mograbi B, Chevallier D, Dadoune JP, Fenichel P, Segretain D, Pointis G. (2003) Impaired gap junction connexin43 in Sertoli cells of patients with secretory azoospermia: a marker of undifferentiated Sertoli cells. Lab Invest 83:3449–456.[ISI][Medline]
Fujita K, Ohta H, Tsujimura A, Takao T, Miyagawa Y, Takada S, Matsumiya K, Wakayama T, Okuyama A. (2005) Transplantation of spermatogonial stem cells isolated from leukemic mice restores fertility without inducing leukemia. J Clin Invest 115:71855–1861.[CrossRef][ISI][Medline]
Johnson L, Zane RS, Petty CS, Neaves WB. (1984) Quantification of the Human Sertoli cell population: its distribution, relation to germ cell numbers, and age-related decline. Biol Reprod 31:785–795.[Abstract]
Johnsen SG. (1970) Testicular biopsy score count—a method for registration of spermatogenesis in human testes: normal values and results in 335 hypogonadal males. Hormones 1:12–25.[Medline]
Martin FH, Suggs SV, Langley KE, Lu HS, Ting J, Okino KH, Morris CF, McNiece IK, Jacobsen FW, Mendiaz EA, et al. (1990) Primary structure and functional expression of rat and human stem cell factor DNAs. Cell 63:1203–211.[CrossRef][ISI][Medline]
Morales C, Hugly S, Griswold MD. (1987) Stage-dependent levels of specific mRNA transcripts in Sertoli cells. Biol Reprod 36:41035–1046.[Abstract]
Mruk DD and Cheng CY. (2004) Sertoli-Sertoli and Sertoli-germ cell interactions and their significance in germ cell movement in the seminiferous epithelium during spermatogenesis. Endocr Rev 25:5747–806.
Nistal M, Jimenez F, Paniagua R. (1990) Sertoli cell types in the Sertoli-cell-only syndrome: relationships between Sertoli cell morphology and aetiology. Histopathology 16:2173–180.[ISI][Medline]
Nistal M, De Mora JC, Paniagua R. (1998) Classification of several types of maturational arrest of spermatogonia according to Sertoli cell morphology: an approach to aetiology. Int J Androl 21:6317–326.[CrossRef][ISI][Medline]
O’Bryan MK, Mallidis C, Murphy BF, Baker HW. (1994) Immunohistological localization of clusterin in the male genital tract in humans and marmosets. Biol Reprod 50:3502–509.[Abstract]
Plotton I, Sanchez P, Perrard MH, Durand P, Lejeune H. (2005) Quantification of stem cell factor mRNA levels in the rat testis: usefulness of clusterin mRNA as a marker of the amount of mRNA of Sertoli cell origin in post pubertal rats. J Endocrinol 186:1131–143.
Regadera J, Martinez-Garcia F, Gonzalez-Peramato P, Serrano A, Nistal M, Suarez-Quian C. (2001) Androgen receptor expression in Sertoli cells as a function of seminiferous tubule maturation in the human cryptorchid testis. J Clin Endocrinol Metab 86:1413–421.
Rossi P, Albanesi C, Grimaldi P, Geremia R. (1991) Expression of the mRNA for the ligand of c-kit in mouse Sertoli cells. Biochem Biophys Res Commun 176:2910–914.[CrossRef][ISI][Medline]
Rossi P, Dolci S, Albanesi C, Grimaldi P, Ricca R, Geremia R. (1993) Follicle-stimulating hormone induction of steel factor (SLF) mRNA in mouse Sertoli cells and stimulation of DNA synthesis in spermatogonia by soluble SLF. Dev Biol 155:168–74.[CrossRef][ISI][Medline]
Schulze C, Holstein AF, Schirren C, Korner F. (1976) On the morphology of the human Sertoli cells under normal conditions and in patients with impaired fertility. Andrologia 8:2167–178.[ISI][Medline]
Sette C, Dolci S, Geremia R, Rossi P. (2000) The role of stem cell factor and of alternative c-kit gene products in the establishment, maintenance and function of germ cells. Int J Dev Biol 44:6599–608.[ISI][Medline]
Sharpe RM, McKinnell C, Kivlin C, Fisher JS. (2003) Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood. Reproduction 125:6769–784.[Abstract]
Tenniswood M, Wang Z, Lakins J, Morrissey C, O’Sullivan J, Tang H. (1998) Clusterin in the male reproductive tract. J Androl 19:5508–516.
Tran D, Picard JY, Campargue J, Josso N. (1987) Immunocytochemical detection of anti-mullerian hormone in Sertoli cells of various mammalian species including human. J Histochem Cytochem 35:7733–743.[Abstract]
Vincent S, Segretain D, Nishikawa S, Nishikawa SI, Sage J, Cuzin F, Rassoulzadegan M. (1998) Stage-specific expression of the Kit receptor and its ligand (KL) during male gametogenesis in the mouse: a Kit-KL interaction critical for meiosis. Development 125:224585–4593.[Abstract]
Wong P, Pineault J, Lakins J, Taillefer D, Leger J, Wang C, Tenniswood M. (1993) Genomic organization and expression of the rat TRPM-2 (clusterin) gene, a gene implicated in apoptosis. J Biol Chem 268:75021–5031.
World Health Organization. (1999) WHO Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interaction (Cambridge University Press, Cambridge).
Wreford NG. (1995) Theory and practice of stereological techniques applied to the estimation of cell number and nuclear volume in the testis. Microse Res Tech 32:423–436.
Yan W, Samson M, Jegou B, Toppari J. (2000) Bcl-w forms complexes with Bax and Bak, and elevated ratios of Bax/Bcl-w and Bak/Bcl-w correspond to spermatogonial and spermatocyte apoptosis in the testis. Mol Endocrinol 14:5682–699.
Submitted on March 22, 2006; resubmitted on April 7, 2006; accepted on April 11, 2006.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||